A RANDOMIZED, PARTIALLY-BLIND, PLACEBO-CONTROLLED, PILOT, DOSE-RANGING STUDY TO ASSESS THE EFFECT OF GWP42003 ON LIVER FAT LEVELS IN SUBJECT WITH FATTY LIVER DISEASE

drug protocol number
GWZMD1188
drug sponsor
GW
drug study
Cannabidiol
drug trial site
KKUH
drug status
Rejected
drug phase